BOTULINUM TOXIN TYPE A

BOTULINUM TOXIN TYPE A was reported 12789 times

These side effects are most commonly reported by patients taking BOTULINUM TOXIN TYPE A:

# Side effect Count
0 OFF LABEL USE 4939
1 DRUG INEFFECTIVE 3736
2 HEADACHE 1657
3 DRUG INTOLERANCE 1376
4 PRODUCT USE IN UNAPPROVED INDICATION 1368
5 NAUSEA 1328
6 MIGRAINE 1211
7 DIZZINESS 1182
8 PAIN 1178
9 HYPOAESTHESIA 1163
10 FATIGUE 1115
11 ASTHENIA 1090
12 MUSCULAR WEAKNESS 1055
13 PARAESTHESIA 985
14 MATERNAL EXPOSURE DURING PREGNANCY 983
15 HYPERTENSION 957
16 GASTROOESOPHAGEAL REFLUX DISEASE 928
17 EPILEPSY 918
18 DYSPNOEA 916
19 CONDITION AGGRAVATED 909
20 DEPRESSION 899
21 VOMITING 898
22 BLEPHAROSPASM 895
23 ABDOMINAL PAIN UPPER 886
24 CONFUSIONAL STATE 864
25 SWELLING 855
26 INTENTIONAL PRODUCT USE ISSUE 847
27 RASH 846
28 HYPERSENSITIVITY 836
29 ARTHRALGIA 835
30 SYSTEMIC LUPUS ERYTHEMATOSUS 831
31 GENERAL PHYSICAL HEALTH DETERIORATION 830
32 PSORIATIC ARTHROPATHY 827
33 ARTHROPATHY 816
34 RHEUMATOID ARTHRITIS 816
35 DRY MOUTH 812
36 PEMPHIGUS 804
37 URTICARIA 796
38 BREAST CANCER STAGE III 795
39 BURSITIS 795
40 TYPE 2 DIABETES MELLITUS 795
41 DIARRHOEA 793
42 MEMORY IMPAIRMENT 789
43 INFUSION RELATED REACTION 788
44 FOLLICULITIS 786
45 PERICARDITIS 786
46 DUODENAL ULCER PERFORATION 785
47 SYNOVITIS 785
48 GLOSSODYNIA 780
49 ALOPECIA 770
50 HAND DEFORMITY 770
51 INFLAMMATION 768
52 TASTE DISORDER 765
53 PRODUCT PREPARATION ERROR 762
54 BLISTER 758
55 C-REACTIVE PROTEIN INCREASED 756
56 HELICOBACTER INFECTION 755
57 NECK PAIN 749
58 ABDOMINAL DISCOMFORT 738
59 FACET JOINT SYNDROME 731
60 MUSCLE SPASMS 728
61 STOMATITIS 717
62 BLOOD CHOLESTEROL INCREASED 716
63 WOUND 715
64 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 713
65 HEPATIC ENZYME INCREASED 706
66 FIBROMYALGIA 705
67 JOINT SWELLING 704
68 WOUND INFECTION 698
69 NASOPHARYNGITIS 686
70 WHEEZING 685
71 PERIPHERAL SWELLING 681
72 PRODUCT QUALITY ISSUE 670
73 PNEUMONIA 665
74 WEIGHT INCREASED 665
75 CONTRAINDICATED PRODUCT ADMINISTERED 664
76 OSTEOARTHRITIS 661
77 IMPAIRED HEALING 658
78 LOWER RESPIRATORY TRACT INFECTION 658
79 MALAISE 657
80 IRRITABLE BOWEL SYNDROME 653
81 MUSCLE INJURY 653
82 HYPERCHOLESTEROLAEMIA 643
83 DRUG HYPERSENSITIVITY 639
84 LIP DRY 637
85 NAIL DISORDER 628
86 PERIPHERAL VENOUS DISEASE 626
87 GAIT INABILITY 625
88 JOINT RANGE OF MOTION DECREASED 616
89 LUNG DISORDER 615
90 LIVER INJURY 613
91 DYSPEPSIA 610
92 OBESITY 605
93 MOBILITY DECREASED 603
94 TREATMENT FAILURE 592
95 MUSCULOSKELETAL PAIN 586
96 SLEEP DISORDER 578
97 PRODUCT USE ISSUE 573
98 BACK INJURY 570
99 INSOMNIA 565
100 NIGHT SWEATS 562
101 OVERDOSE 559
102 MUSCULOSKELETAL STIFFNESS 550
103 LIVE BIRTH 547
104 THERAPEUTIC PRODUCT EFFECT DECREASED 546
105 PAIN IN EXTREMITY 540
106 RHEUMATIC FEVER 539
107 DYSPHAGIA 530
108 ONYCHOMADESIS 522
109 EXPOSURE DURING PREGNANCY 505
110 INJURY 502
111 GASTROINTESTINAL DISORDER 488
112 EYELID PTOSIS 486
113 HYPERHIDROSIS 482
114 GRIP STRENGTH DECREASED 466
115 DRUG-INDUCED LIVER INJURY 465
116 FALL 464
117 SWELLING FACE 464
118 LIVER FUNCTION TEST INCREASED 458
119 INJECTION SITE REACTION 446
120 ILL-DEFINED DISORDER 441
121 NIGHTMARE 435
122 SEDATION 435
123 ABDOMINAL DISTENSION 427
124 COELIAC DISEASE 415
125 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 414
126 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 407
127 DYSPHONIA 404
128 INJECTION SITE PAIN 402
129 C-REACTIVE PROTEIN ABNORMAL 388
130 ONYCHOMYCOSIS 385
131 VISION BLURRED 377
132 ANXIETY 368
133 HEPATITIS 361
134 NEPHROLITHIASIS 359
135 DISCOMFORT 353
136 FINGER DEFORMITY 349
137 DECREASED APPETITE 347
138 THERAPEUTIC RESPONSE SHORTENED 343
139 PRESCRIBED OVERDOSE 330
140 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 325
141 ADVERSE REACTION 320
142 PRODUCT LABEL CONFUSION 319
143 WEIGHT DECREASED 316
144 ABDOMINAL PAIN 311
145 INTENTIONAL PRODUCT MISUSE 303
146 INFLUENZA LIKE ILLNESS 301
147 PYREXIA 298
148 ANGIOEDEMA 290
149 BOTULISM 285
150 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 281
151 SWOLLEN TONGUE 278
152 ASTHMA 276
153 CONTUSION 259
154 CONGENITAL ANOMALY 245
155 PRURITUS 239
156 INFUSION SITE REACTION 233
157 ADVERSE EVENT 232
158 GAIT DISTURBANCE 226
159 UNDERDOSE 216
160 DEATH 213
161 DIPLOPIA 210
162 CHEST PAIN 205
163 FOETAL EXPOSURE DURING PREGNANCY 198
164 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 196
165 INJECTION SITE SWELLING 192
166 SINUSITIS 177
167 FEELING ABNORMAL 175
168 NEUROMUSCULAR TOXICITY 173
169 VISUAL IMPAIRMENT 173
170 TREMOR 171
171 EYE SWELLING 168
172 INFECTION 164
173 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 159
174 THERAPEUTIC RESPONSE DECREASED 159
175 PSORIASIS 155
176 AUTOIMMUNE DISORDER 151
177 OEDEMA 150
178 PRODUCT PREPARATION ISSUE 150
179 LOWER LIMB FRACTURE 149
180 ADVERSE DRUG REACTION 147
181 DRUG EFFECT DECREASED 145
182 EAR PAIN 141
183 FEELING HOT 139
184 BACK PAIN 138
185 BREAST CANCER STAGE II 138
186 EXOSTOSIS 138
187 COUGH 137
188 HEAD DISCOMFORT 136
189 HYPOTENSION 136
190 ARTHRITIS 135
191 PULMONARY FIBROSIS 135
192 MYALGIA 134
193 RED BLOOD CELL SEDIMENTATION RATE INCREASED 134
194 SWOLLEN JOINT COUNT INCREASED 134
195 THERAPY NON-RESPONDER 131
196 PRODUCT STORAGE ERROR 130
197 ERYTHEMA 129
198 DISLOCATION OF VERTEBRA 128
199 INJECTION SITE ERYTHEMA 128
200 SPEECH DISORDER 127
201 BONE EROSION 126
202 MUSCLE SPASTICITY 126
203 FACIAL PARALYSIS 125
204 LARYNGITIS 125
205 RHEUMATOID FACTOR POSITIVE 125
206 NORMAL NEWBORN 124
207 PRESCRIBED UNDERDOSE 124
208 AMNESIA 119
209 VERTIGO 116
210 RESPIRATORY DISORDER 115
211 OVERLAP SYNDROME 112
212 BROW PTOSIS 111
213 DEEP VEIN THROMBOSIS POSTOPERATIVE 109
214 JOINT STIFFNESS 109
215 ENDOMETRIOSIS 106
216 DELIRIUM 105
217 HEPATIC CIRRHOSIS 105
218 PALPITATIONS 105
219 ROAD TRAFFIC ACCIDENT 105
220 SOMNOLENCE 105
221 X-RAY ABNORMAL 105
222 CHRONIC KIDNEY DISEASE 104
223 DYSARTHRIA 104
224 DRY EYE 102
225 MUSCLE TWITCHING 101
226 OEDEMA PERIPHERAL 101
227 SCIATICA 101
228 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 100
229 INJECTION SITE MASS 100
230 HOSPITALISATION 99
231 LUPUS VULGARIS 97
232 CHEST DISCOMFORT 95
233 INCORRECT PRODUCT ADMINISTRATION DURATION 95
234 SEIZURE 92
235 URINARY TRACT INFECTION 91
236 LIVER DISORDER 89
237 LUPUS-LIKE SYNDROME 89
238 FACIAL PARESIS 88
239 DRUG SPECIFIC ANTIBODY 87
240 ULCER HAEMORRHAGE 86
241 MEDICATION ERROR 85
242 CROHN^S DISEASE 84
243 STRESS 82
244 DISTURBANCE IN ATTENTION 80
245 OROPHARYNGEAL PAIN 80
246 OSTEOPOROSIS 80
247 INCORRECT ROUTE OF DRUG ADMINISTRATION 79
248 LOSS OF CONSCIOUSNESS 78
249 TINNITUS 75
250 UPPER RESPIRATORY TRACT INFECTION 75
251 BURNING SENSATION 74
252 HEPATIC ENZYME 74
253 TACHYCARDIA 74
254 EYE PAIN 72
255 DRUG INTERACTION 71
256 FACIAL ASYMMETRY 70
257 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 70
258 INJECTION SITE BRUISING 69
259 PHOTOPHOBIA 69
260 EYELID OEDEMA 67
261 HYPOCHOLESTEROLAEMIA 67
262 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 67
263 FLUSHING 66
264 PERIORBITAL SWELLING 66
265 CEREBROVASCULAR ACCIDENT 65
266 FREQUENT BOWEL MOVEMENTS 65
267 CHILLS 64
268 DYSGEUSIA 64
269 PANIC ATTACK 64
270 RETINITIS 64
271 HEART RATE INCREASED 62
272 NO ADVERSE EVENT 62
273 BRONCHITIS 61
274 DRUG TOLERANCE 61
275 EXTRAPYRAMIDAL DISORDER 60
276 PARADOXICAL DRUG REACTION 60
277 SYNCOPE 60
278 ANURIA 59
279 FACIAL PAIN 59
280 NEOVASCULARISATION 59
281 C-REACTIVE PROTEIN 58
282 TOXICITY TO VARIOUS AGENTS 57
283 WRONG TECHNIQUE IN DRUG USAGE PROCESS 57
284 DISABILITY 56
285 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 56
286 MUSCLE TIGHTNESS 55
287 URINARY RETENTION 55
288 POOR QUALITY SLEEP 54
289 BODY TEMPERATURE INCREASED 53
290 EAR INFECTION 53
291 PANCREATITIS 53
292 PREGNANCY 53
293 CHOKING 52
294 CONSTIPATION 52
295 SWELLING OF EYELID 52
296 THROAT TIGHTNESS 52
297 INJECTION SITE PRURITUS 51
298 IRRITABILITY 51
299 WALKING AID USER 51
300 COVID-19 50
301 OTITIS MEDIA 50
302 PORPHYRIA ACUTE 50
303 NODULE 49
304 WHITE BLOOD CELL COUNT INCREASED 49
305 APHASIA 48
306 EYE DISORDER 48
307 LACRIMATION INCREASED 48
308 CONCUSSION 47
309 NEURALGIA 47
310 LIP SWELLING 46
311 RECTAL HAEMORRHAGE 46
312 HIP ARTHROPLASTY 45
313 MIDDLE INSOMNIA 45
314 ASPIRATION 44
315 BLOOD PRESSURE INCREASED 44
316 DEPRESSED LEVEL OF CONSCIOUSNESS 44
317 MATERNAL EXPOSURE TIMING UNSPECIFIED 44
318 POST-TRAUMATIC NECK SYNDROME 44
319 HYPOAESTHESIA ORAL 43
320 MASTOIDITIS 43
321 OCULAR HYPERAEMIA 43
322 PARANASAL CYST 43
323 SKIN DISCOLOURATION 43
324 VASCULAR MALFORMATION 43
325 ASTHENOPIA 42
326 JOINT DISLOCATION 42
327 MENTAL DISORDER 42
328 RIB FRACTURE 42
329 URINARY INCONTINENCE 42
330 HOSTILITY 41
331 LIBIDO INCREASED 41
332 MYOSITIS 41
333 PARALYSIS 41
334 PERSONALITY DISORDER 41
335 PRODUCT USED FOR UNKNOWN INDICATION 41
336 SOFT TISSUE INJURY 41
337 STERNAL FRACTURE 41
338 KNEE ARTHROPLASTY 40
339 INFLUENZA 39
340 BALANCE DISORDER 38
341 EYE IRRITATION 38
342 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 38
343 PNEUMONIA ASPIRATION 38
344 INJECTION SITE NODULE 37
345 EYE PRURITUS 36
346 LABORATORY TEST ABNORMAL 36
347 LYMPHADENOPATHY 36
348 OXYGEN SATURATION DECREASED 36
349 RESPIRATORY FAILURE 36
350 ELECTROCARDIOGRAM QT PROLONGED 35
351 NERVE INJURY 35
352 RHINORRHOEA 35
353 SEROTONIN SYNDROME 35
354 ANAPHYLACTIC REACTION 34
355 NEPHROPATHY TOXIC 34
356 IMPAIRED WORK ABILITY 33
357 INJECTION SITE HAEMORRHAGE 33
358 LETHARGY 33
359 EAR DISCOMFORT 32
360 LIMB DISCOMFORT 32
361 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 32
362 UNEVALUABLE EVENT 32
363 WHITE BLOOD CELL COUNT DECREASED 32
364 COGNITIVE DISORDER 31
365 DEHYDRATION 31
366 FOOT DEFORMITY 31
367 HERPES ZOSTER 31
368 NASAL CONGESTION 31
369 DRUG SPECIFIC ANTIBODY PRESENT 30
370 FACIAL DISCOMFORT 30
371 ILLNESS 30
372 IMMUNODEFICIENCY 30
373 PERIORBITAL OEDEMA 30
374 PUSTULAR PSORIASIS 30
375 SKIN TIGHTNESS 30
376 SUICIDAL IDEATION 30
377 DEPRESSED MOOD 29
378 HYPOTONIA 29
379 MASTICATION DISORDER 29
380 MOVEMENT DISORDER 29
381 VITREOUS FLOATERS 29
382 EMOTIONAL DISTRESS 28
383 MUSCLE ATROPHY 28
384 SWOLLEN JOINT COUNT 28
385 TENDERNESS 28
386 THERAPY PARTIAL RESPONDER 28
387 CYSTITIS 27
388 RASH VESICULAR 27
389 APHONIA 26
390 COLITIS ULCERATIVE 26
391 FACE OEDEMA 26
392 FLUID RETENTION 26
393 INJECTION SITE DISCOMFORT 26
394 INJECTION SITE URTICARIA 26
395 RASH PRURITIC 26
396 VIRAL INFECTION 26
397 BACK DISORDER 25
398 BRAIN INJURY 25
399 CARDIAC DISORDER 25
400 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 25
401 DYSKINESIA 25
402 MATERNAL EXPOSURE BEFORE PREGNANCY 25
403 DRUG TOLERANCE DECREASED 24
404 THROAT IRRITATION 24
405 TREATMENT NONCOMPLIANCE 24
406 ANGINA PECTORIS 23
407 DYSTONIA 23
408 EYE MOVEMENT DISORDER 23
409 MYOCARDIAL INFARCTION 23
410 PHOTOSENSITIVITY REACTION 23
411 PRODUCT TEMPERATURE EXCURSION ISSUE 23
412 RESPIRATORY DISTRESS 23
413 SCAR 23
414 STRABISMUS 23
415 EYE INJURY 22
416 IMPAIRED DRIVING ABILITY 22
417 PAIN IN JAW 22
418 RASH ERYTHEMATOUS 22
419 RASH PAPULAR 22
420 SKIN WRINKLING 22
421 SUSPECTED OFF LABEL USE 22
422 VISUAL FIELD DEFECT 22
423 BLINDNESS 21
424 BRADYCARDIA 21
425 CONVULSION 21
426 DYSPNOEA EXERTIONAL 21
427 DYSURIA 21
428 GENERAL SYMPTOM 21
429 HEMIPARESIS 21
430 INCORRECT DOSE ADMINISTERED 21
431 NERVOUSNESS 21
432 OCULAR DISCOMFORT 21
433 PRODUCT DOSE OMISSION ISSUE 21
434 TENSION HEADACHE 21
435 ACNE 20
436 BONE PAIN 20
437 BRAIN FOG 20
438 CELLULITIS 20
439 CRYING 20
440 HYPOKALAEMIA 20
441 LIP DISORDER 20
442 ACCIDENTAL OVERDOSE 19
443 ANAEMIA 19
444 ARTERIOSCLEROSIS CORONARY ARTERY 19
445 DRUG RESISTANCE 19
446 DRY SKIN 19
447 DYSSTASIA 19
448 FEEDING DISORDER 19
449 MASS 19
450 MYASTHENIA GRAVIS 19
451 PALLOR 19
452 PRESYNCOPE 19
453 BLOOD PRESSURE DECREASED 18
454 DRUG DEPENDENCE 18
455 FEAR 18
456 FOOD INTOLERANCE 18
457 INJECTION SITE DISCOLOURATION 18
458 INJECTION SITE RASH 18
459 LEFT VENTRICULAR FAILURE 18
460 MUSCLE DISORDER 18
461 MUSCULOSKELETAL DISCOMFORT 18
462 PARANASAL SINUS DISCOMFORT 18
463 PRODUCT PACKAGING ISSUE 18
464 SENSORY DISTURBANCE 18
465 SKIN DISORDER 18
466 WEIGHT FLUCTUATION 18
467 ERYTHEMA OF EYELID 17
468 LEUKOPENIA 17
469 MUSCLE CONTRACTIONS INVOLUNTARY 17
470 SINUS DISORDER 17
471 SPONDYLITIS 17
472 SUSPECTED COUNTERFEIT PRODUCT 17
473 THERAPEUTIC RESPONSE UNEXPECTED 17
474 VISUAL ACUITY REDUCED 17
475 VOCAL CORD PARALYSIS 17
476 ADRENAL INSUFFICIENCY 16
477 BELL^S PALSY 16
478 DROOLING 16
479 EXPIRED PRODUCT ADMINISTERED 16
480 HAEMOGLOBIN DECREASED 16
481 HYDROCEPHALUS 16
482 INCONTINENCE 16
483 INCORRECT PRODUCT STORAGE 16
484 INJECTION SITE PARAESTHESIA 16
485 JOINT DESTRUCTION 16
486 MULTIPLE SCLEROSIS 16
487 OROPHARYNGEAL DISCOMFORT 16
488 PHOTOPSIA 16
489 RASH GENERALISED 16
490 SKIN EXFOLIATION 16
491 ABORTION SPONTANEOUS 15
492 BLADDER NEOPLASM 15
493 BLOOD PRESSURE FLUCTUATION 15
494 DENTAL CARIES 15
495 EATING DISORDER 15
496 EYE INFECTION 15
497 EYELID DISORDER 15
498 GASTRIC DISORDER 15
499 INJECTION SITE INFLAMMATION 15
500 LICHEN PLANUS 15
501 MIGRAINE WITH AURA 15
502 NEUROPATHY PERIPHERAL 15
503 PRODUCT ADMINISTERED BY WRONG PERSON 15
504 SERONEGATIVE ARTHRITIS 15
505 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 14
506 CHOKING SENSATION 14
507 HEART RATE DECREASED 14
508 HYPERACUSIS 14
509 INJECTION SITE HYPOAESTHESIA 14
510 INJECTION SITE INDENTATION 14
511 INJECTION SITE WARMTH 14
512 MOTOR DYSFUNCTION 14
513 MYDRIASIS 14
514 NERVOUS SYSTEM DISORDER 14
515 PRODUCT ADMINISTRATION ERROR 14
516 PRODUCTIVE COUGH 14
517 RESPIRATORY TRACT INFECTION 14
518 SENSATION OF FOREIGN BODY 14
519 THYROID DISORDER 14
520 TRISMUS 14
521 VASCULAR GRAFT OCCLUSION 14
522 ABORTION MISSED 13
523 BLOOD CREATINE PHOSPHOKINASE INCREASED 13
524 DIABETES MELLITUS 13
525 DISORIENTATION 13
526 DRUG ABUSE 13
527 HEART RATE IRREGULAR 13
528 HYPERTRANSAMINASAEMIA 13
529 HYPOACUSIS 13
530 INJECTION SITE INDURATION 13
531 MYASTHENIC SYNDROME 13
532 OPHTHALMOPLEGIA 13
533 POLYARTHRITIS 13
534 PULMONARY EMBOLISM 13
535 SKIN LESION 13
536 SKIN REACTION 13
537 TORTICOLLIS 13
538 UROSEPSIS 13
539 VIITH NERVE PARALYSIS 13
540 ACTIVITIES OF DAILY LIVING IMPAIRED 12
541 BACTERIAL INFECTION 12
542 BLINDNESS TRANSIENT 12
543 DEAFNESS 12
544 DILATED CARDIOMYOPATHY 12
545 DRY THROAT 12
546 ECZEMA 12
547 EYE DISCHARGE 12
548 FUNGAL SKIN INFECTION 12
549 HEMIPLEGIA 12
550 HYPOPHAGIA 12
551 IMPAIRED GASTRIC EMPTYING 12
552 INJECTION SITE HAEMATOMA 12
553 JAW DISORDER 12
554 LAGOPHTHALMOS 12
555 MENTAL IMPAIRMENT 12
556 NASAL DISCOMFORT 12
557 PAPULE 12
558 PHARYNGITIS STREPTOCOCCAL 12
559 POISONING 12
560 POSTURE ABNORMAL 12
561 PROCEDURAL ANXIETY 12
562 PROCEDURAL PAIN 12
563 RESPIRATORY ARREST 12
564 SALIVARY HYPERSECRETION 12
565 SKIN INDENTATION 12
566 SPINAL FUSION SURGERY 12
567 SUSPECTED PRODUCT QUALITY ISSUE 12
568 TOOTHACHE 12
569 TRANSIENT ISCHAEMIC ATTACK 12
570 ACCIDENTAL EXPOSURE TO PRODUCT 11
571 BEDRIDDEN 11
572 CHANGE OF BOWEL HABIT 11
573 DIAPHRAGMATIC RUPTURE 11
574 DISEASE PROGRESSION 11
575 DRUG EFFECT INCOMPLETE 11
576 EYE CONTUSION 11
577 HAEMORRHAGE 11
578 HOT FLUSH 11
579 HYPERAESTHESIA 11
580 HYPOKINESIA 11
581 INJECTION SITE IRRITATION 11
582 INJECTION SITE OEDEMA 11
583 MAJOR DEPRESSION 11
584 MENOPAUSE 11
585 MONOPLEGIA 11
586 MULTIPLE SCLEROSIS RELAPSE 11
587 MUSCULOSKELETAL DISORDER 11
588 NEOPLASM MALIGNANT 11
589 PAROSMIA 11
590 POST-TRAUMATIC HEADACHE 11
591 RASH MACULAR 11
592 SEPSIS 11
593 SEPTIC SHOCK 11
594 SKIN MASS 11
595 SURGERY 11
596 VITAMIN D DECREASED 11
597 AGITATION 10
598 ATRIOVENTRICULAR SEPTAL DEFECT 10
599 CARDIAC ARREST 10
600 CEREBRAL HAEMORRHAGE 10
601 CONJUNCTIVAL HAEMORRHAGE 10
602 DEEP VEIN THROMBOSIS 10
603 DERMATITIS 10
604 GENERALISED TONIC-CLONIC SEIZURE 10
605 GRIP STRENGTH 10
606 HAEMATOMA 10
607 HAEMATURIA 10
608 HYPOGLYCAEMIA 10
609 IMPAIRED QUALITY OF LIFE 10
610 LOCAL SWELLING 10
611 MEPHISTO SIGN 10
612 MOOD ALTERED 10
613 MYOPATHY 10
614 PANIC REACTION 10
615 PERIORBITAL PAIN 10
616 PERIPHERAL COLDNESS 10
617 PRODUCT ADMINISTERED FROM UNAUTHORISED PROVIDER 10
618 RASH PUSTULAR 10
619 SINUS PAIN 10
620 SNEEZING 10
621 TROPONIN INCREASED 10
622 ABASIA 9
623 ACUTE MYOCARDIAL INFARCTION 9
624 AORTIC STENOSIS 9
625 ARRHYTHMIA 9
626 ATAXIA 9
627 BLADDER DISORDER 9
628 BLEPHARITIS 9
629 BLOOD PRESSURE DIASTOLIC ABNORMAL 9
630 BLOOD PRESSURE DIASTOLIC DECREASED 9
631 CARDIO-RESPIRATORY ARREST 9
632 CEREBRAL DISORDER 9
633 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9
634 COMA 9
635 DEFORMITY 9
636 EYELID FUNCTION DISORDER 9
637 EYELID PAIN 9
638 FACIAL SPASM 9
639 GRANULOMA 9
640 HEAD INJURY 9
641 HIP FRACTURE 9
642 MADAROSIS 9
643 ORAL DISCOMFORT 9
644 PAIN OF SKIN 9
645 PARESIS 9
646 PETIT MAL EPILEPSY 9
647 PLATELET COUNT DECREASED 9
648 PLEURAL EFFUSION 9
649 POST PROCEDURAL COMPLICATION 9
650 RELAPSING MULTIPLE SCLEROSIS 9
651 RESTLESSNESS 9
652 SKIN IRRITATION 9
653 SKIN LACERATION 9
654 SLOW SPEECH 9
655 ACUTE KIDNEY INJURY 8
656 ANAL INCONTINENCE 8
657 BREAST CANCER 8
658 CARDIAC FAILURE 8
659 CATARACT 8
660 COLD SWEAT 8
661 CYST 8
662 DEAFNESS UNILATERAL 8
663 DERMATITIS ALLERGIC 8
664 DERMATOCHALASIS 8
665 DRUG EFFECT LESS THAN EXPECTED 8
666 ELECTRIC SHOCK SENSATION 8
667 EPISTAXIS 8
668 FEELING OF BODY TEMPERATURE CHANGE 8
669 GASTRITIS 8
670 GASTROENTERITIS VIRAL 8
671 HALLUCINATION 8
672 HEAD TITUBATION 8
673 HYPOXIA 8
674 INJECTION SITE PAPULE 8
675 INTRACRANIAL PRESSURE INCREASED 8
676 MYOCLONUS 8
677 OCCIPITAL NEURALGIA 8
678 PARAESTHESIA ORAL 8
679 PHARYNGITIS 8
680 POLLAKIURIA 8
681 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 8
682 PRODUCT RECONSTITUTION ISSUE 8
683 PRURITUS GENERALISED 8
684 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 8
685 RHABDOMYOLYSIS 8
686 SINUS CONGESTION 8
687 SPINAL STENOSIS 8
688 STAPHYLOCOCCAL INFECTION 8
689 STRIDOR 8
690 SUPRAVENTRICULAR TACHYCARDIA 8
691 THINKING ABNORMAL 8
692 THIRST 8
693 THROMBOCYTOPENIA 8
694 THROMBOSIS 8
695 ABNORMAL BEHAVIOUR 7
696 ACCOMMODATION DISORDER 7
697 ANAPHYLACTIC SHOCK 7
698 ATRIAL FIBRILLATION 7
699 BLINDNESS UNILATERAL 7
700 BLOOD GLUCOSE INCREASED 7
701 CONCOMITANT DISEASE AGGRAVATED 7
702 CONGESTIVE CARDIOMYOPATHY 7
703 CYANOSIS 7
704 DERMATITIS CONTACT 7
705 EMOTIONAL DISORDER 7
706 ENCEPHALITIS 7
707 EYELIDS PRURITUS 7
708 FINE MOTOR SKILL DYSFUNCTION 7
709 GINGIVAL BLEEDING 7
710 HAEMATOCHEZIA 7
711 HERPES VIRUS INFECTION 7
712 INCORRECT DRUG ADMINISTRATION DURATION 7
713 INJECTION SITE INFECTION 7
714 INJECTION SITE VESICLES 7
715 KIDNEY INFECTION 7
716 MENSTRUAL DISORDER 7
717 MICTURITION URGENCY 7
718 MULTIPLE USE OF SINGLE-USE PRODUCT 7
719 MUSCLE FATIGUE 7
720 MUSCLE HYPERTROPHY 7
721 MYCOBACTERIAL INFECTION 7
722 MYCOBACTERIUM ABSCESSUS INFECTION 7
723 NAIL OPERATION 7
724 ORTHOSTATIC HYPOTENSION 7
725 OTITIS MEDIA ACUTE 7
726 PALATAL DISORDER 7
727 PATIENT DISSATISFACTION WITH TREATMENT 7
728 PNEUMOTHORAX 7
729 PRODUCT PRESCRIBING ISSUE 7
730 PRODUCT QUALITY CONTROL ISSUE 7
731 PYELONEPHRITIS 7
732 SCAB 7
733 SENSORY LOSS 7
734 SKIN BURNING SENSATION 7
735 SKIN SWELLING 7
736 TONGUE PARALYSIS 7
737 UPPER-AIRWAY COUGH SYNDROME 7
738 VASCULAR OCCLUSION 7
739 VITREOUS DETACHMENT 7
740 ABNORMAL SENSATION IN EYE 6
741 ACUTE RESPIRATORY FAILURE 6
742 AGEUSIA 6
743 ALLODYNIA 6
744 ANEURYSM 6
745 ANOSMIA 6
746 APPLICATION SITE PAIN 6
747 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6
748 BLADDER PAIN 6
749 BRAIN NEOPLASM 6
750 BREAST PAIN 6
751 BRONCHIAL HYPERREACTIVITY 6
752 CHOLELITHIASIS 6
753 CONJUNCTIVITIS 6
754 DARK CIRCLES UNDER EYES 6
755 DEAFNESS NEUROSENSORY 6
756 DEREALISATION 6
757 EAR CONGESTION 6
758 EXPOSURE VIA BREAST MILK 6
759 EYE HAEMORRHAGE 6
760 EYE OEDEMA 6
761 EYELID IRRITATION 6
762 EYELID MARGIN CRUSTING 6
763 FEELING DRUNK 6
764 FORMICATION 6
765 FRUSTRATION TOLERANCE DECREASED 6
766 GINGIVITIS 6
767 HAND FRACTURE 6
768 HEPATIC CYTOLYSIS 6
769 HYPERTHYROIDISM 6
770 HYPERTONIA 6
771 INJECTION SITE ATROPHY 6
772 INTERVERTEBRAL DISC DEGENERATION 6
773 INTESTINAL OBSTRUCTION 6
774 LIP PAIN 6
775 MOOD SWINGS 6
776 MOUTH ULCERATION 6
777 MUSCLE RIGIDITY 6
778 NOROVIRUS INFECTION 6
779 ORAL PAIN 6
780 PERITONITIS 6
781 PERONEAL NERVE PALSY 6
782 PHARYNGEAL HYPOAESTHESIA 6
783 PHARYNGEAL OEDEMA 6
784 PHARYNGEAL SWELLING 6
785 PHYSICAL DISABILITY 6
786 POOR QUALITY PRODUCT ADMINISTERED 6
787 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6
788 PRODUCT COMPLAINT 6
789 REFUSAL OF TREATMENT BY PATIENT 6
790 RHINALGIA 6
791 SACRAL PAIN 6
792 SECRETION DISCHARGE 6
793 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 6
794 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 6
795 SUPERINFECTION 6
796 SUSPECTED COVID-19 6
797 SYMPTOM RECURRENCE 6
798 TENSION 6
799 VENTRICULAR FIBRILLATION 6
800 VIRAL UPPER RESPIRATORY TRACT INFECTION 6
801 ABDOMINAL PAIN LOWER 5
802 ABERRANT AORTIC ARCH 5
803 ACQUIRED DIAPHRAGMATIC EVENTRATION 5
804 ACUTE RESPIRATORY DISTRESS SYNDROME 5
805 APATHY 5
806 APPLICATION SITE PAPULES 5
807 ASPHYXIA 5
808 AURA 5
809 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5
810 BIPOLAR DISORDER 5
811 BLADDER SPASM 5
812 BLOOD POTASSIUM DECREASED 5
813 BODY TEMPERATURE DECREASED 5
814 BREAST DISORDER 5
815 BRUXISM 5
816 CHONDROPATHY 5
817 CIRCULATORY COLLAPSE 5
818 COORDINATION ABNORMAL 5
819 DEVICE ISSUE 5
820 DYSGRAPHIA 5
821 DYSPHEMIA 5
822 EFFUSION 5
823 EMBOLISM 5
824 EPIGASTRIC DISCOMFORT 5
825 FACIAL NERVE DISORDER 5
826 FACIAL PALSY 5
827 FEELING COLD 5
828 FLATULENCE 5
829 GASTROENTERITIS NOROVIRUS 5
830 GENERALISED OEDEMA 5
831 GINGIVAL PAIN 5
832 GINGIVAL SWELLING 5
833 HORDEOLUM 5
834 HYPERCAPNIA 5
835 HYPERTONIC BLADDER 5
836 HYPONATRAEMIA 5
837 HYPOTHYROIDISM 5
838 IATROGENIC INJURY 5
839 INFLAMMATORY PAIN 5
840 INFRAPATELLAR FAT PAD INFLAMMATION 5
841 INJECTION SITE EXTRAVASATION 5
842 INTERVERTEBRAL DISC PROTRUSION 5
843 LARYNGOSPASM 5
844 LENNOX-GASTAUT SYNDROME 5
845 LID SULCUS DEEPENED 5
846 LYMPHOCYTE COUNT DECREASED 5
847 MENINGIOMA 5
848 MENISCUS INJURY 5
849 MUSCLE STRAIN 5
850 MYOCLONIC EPILEPSY 5
851 NASAL OEDEMA 5
852 NEUROLOGICAL SYMPTOM 5
853 NYSTAGMUS 5
854 OPHTHALMIC HERPES ZOSTER 5
855 ORAL CANDIDIASIS 5
856 ORAL DISORDER 5
857 ORAL HERPES 5
858 PERIORBITAL CELLULITIS 5
859 POLYNEUROPATHY 5
860 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 5
861 PRE-ECLAMPSIA 5
862 PRIMARY STABBING HEADACHE 5
863 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 5
864 PUSTULE 5
865 QUALITY OF LIFE DECREASED 5
866 REDUCED FACIAL EXPRESSION 5
867 RENAL PAIN 5
868 RESPIRATION ABNORMAL 5
869 RETROPERITONEAL HAEMATOMA 5
870 SACROILIITIS 5
871 SENSITIVE SKIN 5
872 SINUS HEADACHE 5
873 SKIN HYPOPIGMENTATION 5
874 SLEEP APNOEA SYNDROME 5
875 STEVENS-JOHNSON SYNDROME 5
876 TEARFULNESS 5
877 TENDON DISORDER 5
878 TERMINAL INSOMNIA 5
879 THERAPEUTIC PRODUCT EFFECT DELAYED 5
880 THERAPY CESSATION 5
881 TONGUE DISORDER 5
882 VENTRICULAR SEPTAL DEFECT 5
883 ACNE CYSTIC 4
884 ADMINISTRATION SITE BRUISE 4
885 AGGRESSION 4
886 ALTERED STATE OF CONSCIOUSNESS 4
887 AMNESTIC DISORDER 4
888 ANGER 4
889 APPENDICITIS 4
890 AREFLEXIA 4
891 ARTHROPOD BITE 4
892 AUTISM SPECTRUM DISORDER 4
893 BLADDER DYSFUNCTION 4
894 BLOOD CALCIUM INCREASED 4
895 BLOOD GLUCOSE DECREASED 4
896 BLOOD PRESSURE SYSTOLIC INCREASED 4
897 BRADYKINESIA 4
898 BRAIN OEDEMA 4
899 CATHETER SITE PAIN 4
900 CENTRAL NERVOUS SYSTEM LESION 4
901 CERVICAL SPINAL STENOSIS 4
902 CHROMATURIA 4
903 CYSTITIS NONINFECTIVE 4
904 DECUBITUS ULCER 4
905 DIAPHRAGMATIC PARALYSIS 4
906 DISEASE RECURRENCE 4
907 DRUG ADMINISTRATION ERROR 4
908 DRUG EFFECT INCREASED 4
909 DRUG TOXICITY 4
910 DYSLEXIA 4
911 EAR DISORDER 4
912 EAR SWELLING 4
913 ERECTILE DYSFUNCTION 4
914 EXOPHTHALMOS 4
915 EXTRAOCULAR MUSCLE PARESIS 4
916 EXTRASYSTOLES 4
917 EYE INFLAMMATION 4
918 FACE INJURY 4
919 FEELING JITTERY 4
920 FOETAL GROWTH RESTRICTION 4
921 FOOT FRACTURE 4
922 FOREIGN BODY SENSATION IN EYES 4
923 GASTROENTERITIS 4
924 GASTROINTESTINAL HAEMORRHAGE 4
925 GASTROINTESTINAL MOTILITY DISORDER 4
926 GENITAL HERPES 4
927 GUILLAIN-BARRE SYNDROME 4
928 HAEMATEMESIS 4
929 HEAVY MENSTRUAL BLEEDING 4
930 HYPERREFLEXIA 4
931 HYPERVENTILATION 4
932 HYPOAESTHESIA EYE 4
933 INAPPROPRIATE AFFECT 4
934 INCISION SITE PAIN 4
935 INFLAMMATORY BOWEL DISEASE 4
936 INJECTION SITE ABSCESS 4
937 INJECTION SITE HYPERSENSITIVITY 4
938 INJECTION SITE SCAR 4
939 JOB DISSATISFACTION 4
940 JOINT NOISE 4
941 KERATITIS 4
942 KNEE OPERATION 4
943 LACRIMATION DECREASED 4
944 LIGAMENT SPRAIN 4
945 LIP EXFOLIATION 4
946 LYMPH NODE PAIN 4
947 LYMPHOEDEMA 4
948 METABOLIC ACIDOSIS 4
949 MIOSIS 4
950 MONOPARESIS 4
951 MOUTH SWELLING 4
952 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4
953 NASAL DRYNESS 4
954 NEEDLE ISSUE 4
955 NEOPLASM PROGRESSION 4
956 NEURALGIC AMYOTROPHY 4
957 NEUROLEPTIC MALIGNANT SYNDROME 4
958 NEUROMYOPATHY 4
959 NEUROPATHIC MUSCULAR ATROPHY 4
960 NEUTRALISING ANTIBODIES 4
961 OCULOGYRIC CRISIS 4
962 OESOPHAGEAL SPASM 4
963 PANIC DISORDER 4
964 PELVIC PAIN 4
965 PEMPHIGOID 4
966 PETECHIAE 4
967 PHARYNGEAL DISORDER 4
968 POOR QUALITY DRUG ADMINISTERED 4
969 POOR VENOUS ACCESS 4
970 POST VIRAL FATIGUE SYNDROME 4
971 PRODUCT DOSE OMISSION 4
972 QUADRIPARESIS 4
973 RENAL FAILURE 4
974 RENAL IMPAIRMENT 4
975 RETCHING 4
976 RETINAL DETACHMENT 4
977 ROTATOR CUFF SYNDROME 4
978 SALIVARY GLAND PAIN 4
979 SCLERODERMA 4
980 SCOLIOSIS 4
981 SENSATION OF HEAVINESS 4
982 SEXUAL DYSFUNCTION 4
983 SHOCK 4
984 SKIN CANCER 4
985 SKIN INFECTION 4
986 SKIN LAXITY 4
987 SUFFOCATION FEELING 4
988 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4
989 TEMPERATURE INTOLERANCE 4
990 TEMPOROMANDIBULAR JOINT SYNDROME 4
991 THERAPY INTERRUPTED 4
992 TONGUE DISCOMFORT 4
993 TONGUE DRY 4
994 TRIGEMINAL NEURALGIA 4
995 TYPE IV HYPERSENSITIVITY REACTION 4
996 VASCULITIS 4
997 VEIN DISORDER 4
998 WALKING DISABILITY 4
999 WRONG PRODUCT ADMINISTERED 4